Sofosbuvir + Ribavirin Cures Many with Hepatitis C in Phase II Clinical Trial | Hepatitis Central

The latest research & treatment news about Hepatitis C infection, diagnosis, symptoms and treatment.

Menu Search
Previous

Liver Cell Transplant On Baby Is a Success in Japan

Back to News Homepage
Next

Kids Have Hep C Too

Sofosbuvir + Ribavirin Cures Many with Hepatitis C in Phase II Clinical Trial

The Editors at Hepatitis Central
August 28, 2013

Print this page

Read the details about a Phase II Clinical Trial which highlights compelling evidence that interferon-free regimens can be safe and effective.

Hepatitis C Cure? Sofosbuvir Plus Ribavirin Eliminate Liver Infection In Promising NIH Trial

By Nsikan Akpan | Aug 27, 2013

Hepatitis C patients who don’t normally respond to standard treatment may have a new weapon for fighting their viral liver disease. A combination drug program, with sofosbuvir and ribavirin, has cured a majority of volunteers in a Phase II clinical trial conducted by the National Institute of Allergy and Infectious Disease (NIAID), a branch of the National Institutes of Health (NIH).

Continue reading this entire article:
http://www.medicaldaily.com/hepatitis-c-cure-sofosbuvir-plus-ribavirin-eliminate-liver-infection-promising-nih-trial-254613

15 Comments
Share
Share
Previous

Liver Cell Transplant On Baby Is a Success in Japan

Back to News Homepage
Next

Kids Have Hep C Too

Requirements for using and reposting articles

Comments

HepatitisCentral.com provides information regarding hepatitis and liver disease. Comments are available to the community in order to discuss these topics and obtain answers to questions through community members. The Editors at HepatitisCentral.com will not be responding to questions or comments posed in article comments.